STOCK TITAN

Vanguard reorganizes reporting; affiliates to report DOCS holdings (DOCS)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

The Vanguard Group amended its Schedule 13G to report zero shares beneficially owned of Doximity Inc. The filing states that on January 12, 2026 The Vanguard Group, Inc. underwent an internal realignment and certain subsidiaries will report beneficial ownership separately in reliance on SEC Release No. 34-39538.

The amendment lists 0 shares beneficially owned and 0% of the class, and explains that Vanguard no longer is deemed to beneficially own shares held by those reorganized subsidiaries.

Positive

  • None.

Negative

  • None.

Insights

Vanguard reports no beneficial ownership after internal realignment.

The amended Schedule 13G/A shows 0 shares and 0% ownership, stating that Vanguard realigned on January 12, 2026 and subsidiaries will report separately under SEC Release No. 34-39538. This is a reclassification of reporting responsibility, not a disclosed sale.

Practical implications depend on the subsidiary filings that follow; subsequent 13G/A or 13D entries by the individual subsidiaries will show where holdings are now reported.

Administrative disclosure reflecting disaggregation of beneficial ownership.

The filing attributes the change to an internal reorganization and cites SEC Release No. 34-39538 as the legal basis for separate reporting by subsidiaries. The statement clarifies that those subsidiaries pursue the same investment strategies previously used by Vanguard.

Observe subsequent filings from Vanguard affiliates for details on which entities hold shares and any reported percentages; timing and cash‑flow treatment are not included here.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/26/2026

FAQ

What change did The Vanguard Group report for DOCS ownership?

The Vanguard Group reported 0 shares beneficially owned of Doximity Inc, representing 0% of the class. The filing attributes this to an internal realignment effective January 12, 2026, with subsidiaries to report separately.

Does the amendment indicate Vanguard sold DOCS shares?

No. The filing describes an internal realignment and states subsidiaries will report separately under SEC Release No. 34-39538 rather than documenting any specific sale or transfer of securities.

Will Vanguard affiliates still manage the same investments after realignment?

Yes. The amendment states the subsidiaries and business divisions "pursue the same investment strategies" previously used by The Vanguard Group, Inc., while reporting beneficial ownership separately under the cited SEC release.

Where will DOCS holdings be reported after this amendment?

The amendment indicates that certain subsidiaries or business divisions will report beneficial ownership separately; those affiliates' future Schedule 13G/13D filings should disclose their respective holdings and percentages.

Who signed the Schedule 13G/A amendment for Vanguard?

The form is signed by Ashley Grim, Head of Global Fund Administration, with a signature date of 03/26/2026, attesting to the amended ownership statement.
Doximity Inc

NYSE:DOCS

View DOCS Stock Overview

DOCS Rankings

DOCS Latest News

DOCS Latest SEC Filings

DOCS Stock Data

4.47B
130.34M
Health Information Services
Services-computer Programming Services
Link
United States
SAN FRANCISCO